ES548196A0 - Un procedimiento para la preparacion de nuevos derivados de 1,5-benzotiazepina - Google Patents

Un procedimiento para la preparacion de nuevos derivados de 1,5-benzotiazepina

Info

Publication number
ES548196A0
ES548196A0 ES548196A ES548196A ES548196A0 ES 548196 A0 ES548196 A0 ES 548196A0 ES 548196 A ES548196 A ES 548196A ES 548196 A ES548196 A ES 548196A ES 548196 A0 ES548196 A0 ES 548196A0
Authority
ES
Spain
Prior art keywords
lower alkyl
derivatives
benzotiazepine
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES548196A
Other languages
English (en)
Other versions
ES8702390A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Seiyaku Co Ltd
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Publication of ES548196A0 publication Critical patent/ES548196A0/es
Publication of ES8702390A1 publication Critical patent/ES8702390A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
ES548196A 1983-06-11 1985-10-24 Un procedimiento para la preparacion de nuevos derivados de 1,5-benzotiazepina Expired ES8702390A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838316032A GB8316032D0 (en) 1983-06-11 1983-06-11 Benzothiazepine derivatives

Publications (2)

Publication Number Publication Date
ES548196A0 true ES548196A0 (es) 1986-12-16
ES8702390A1 ES8702390A1 (es) 1986-12-16

Family

ID=10544142

Family Applications (2)

Application Number Title Priority Date Filing Date
ES533282A Expired ES8604185A1 (es) 1983-06-11 1984-06-08 Un procedimiento para la preparacion de nuevos derivados de 1,5-benzotiazepina.
ES548196A Expired ES8702390A1 (es) 1983-06-11 1985-10-24 Un procedimiento para la preparacion de nuevos derivados de 1,5-benzotiazepina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES533282A Expired ES8604185A1 (es) 1983-06-11 1984-06-08 Un procedimiento para la preparacion de nuevos derivados de 1,5-benzotiazepina.

Country Status (13)

Country Link
US (1) US4521430A (es)
EP (1) EP0128462B1 (es)
JP (1) JPS59231076A (es)
KR (1) KR890000019B1 (es)
AT (1) ATE41659T1 (es)
AU (1) AU563094B2 (es)
CA (1) CA1218651A (es)
DE (1) DE3477380D1 (es)
DK (1) DK172192B1 (es)
ES (2) ES8604185A1 (es)
GB (1) GB8316032D0 (es)
HK (1) HK1491A (es)
SG (1) SG54490G (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4585768A (en) * 1984-04-10 1986-04-29 Tanabe Seiyaku Co., Ltd. 1,5-benzothiazepine derivatives and processes for preparing the same
IL71538A (en) * 1984-04-13 1987-07-31 Abic Ltd Process for the preparation of benzothiazepine derivatives
USRE33072E (en) * 1985-06-20 1989-09-26 E. R. Squibb & Sons, Inc. Benzothiazepine derivatives
US4584131A (en) * 1985-06-20 1986-04-22 E. R. Squibb & Sons, Inc. Benzothiazepine derivatives
JPS649981A (en) * 1987-06-29 1989-01-13 Tanabe Seiyaku Co 1,5-benzothiazepine derivative
US4912102A (en) * 1988-02-01 1990-03-27 Hoffmann-La Roche Inc. Analogs of naphtho[1,2-β] [1,4] thiazepin-4(5H)-one
US4902684A (en) * 1988-06-20 1990-02-20 E. R. Squibb & Sons, Inc. Benzazepine and benzothiazepine derivatives
FR2638745B1 (fr) * 1988-11-08 1994-01-14 Synthelabo Derives de ((n-alkylthioalkyl-methylamino)-2 ethyl)-5 benzothiazepine-1,5 one-4, leur preparation et leur application en therapeutique
CA2077265A1 (en) * 1991-01-10 1992-07-11 Andrew Young Amylin activity assays

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1236467A (en) * 1967-10-28 1971-06-23 Tanabe Seiyaku Co Benzothiazepine derivatives
DE1923568A1 (de) * 1969-05-08 1970-11-12 Squibb & Sons Inc Benzothiazepine,ihre Salze mit Saeuren und quartaeren Ammoniumsalze
JPS5899471A (ja) * 1981-12-07 1983-06-13 Tanabe Seiyaku Co Ltd ベンゾチアゼピン誘導体の新規製造法

Also Published As

Publication number Publication date
GB8316032D0 (en) 1983-07-13
KR890000019B1 (ko) 1989-03-06
EP0128462A1 (en) 1984-12-19
DK172192B1 (da) 1997-12-22
DK283984A (da) 1984-12-12
ATE41659T1 (de) 1989-04-15
ES533282A0 (es) 1986-01-16
SG54490G (en) 1990-09-07
ES8604185A1 (es) 1986-01-16
KR850000421A (ko) 1985-02-27
ES8702390A1 (es) 1986-12-16
JPH0374221B2 (es) 1991-11-26
JPS59231076A (ja) 1984-12-25
US4521430A (en) 1985-06-04
DK283984D0 (da) 1984-06-08
HK1491A (en) 1991-01-11
DE3477380D1 (en) 1989-04-27
AU2887584A (en) 1984-12-13
CA1218651A (en) 1987-03-03
AU563094B2 (en) 1987-06-25
EP0128462B1 (en) 1989-03-22

Similar Documents

Publication Publication Date Title
ES533009A0 (es) Un procedimiento para la preparacion de nuevos derivados de 8-cloro71,5-benzotiazepina.
ES549629A0 (es) Un procedimiento para preparar derivados de dihidropiridazi-nona
DE69021755D1 (de) Benzopyranderivate und Verfahren zu ihrer Herstellung.
ES557306A0 (es) Procedimiento para preparar derivados de acido quinoloncarboxilico
ES533282A0 (es) Un procedimiento para la preparacion de nuevos derivados de 1,5-benzotiazepina.
ES548898A0 (es) Un procedimiento para la preparacion de derivados de 1,5-benzotiazepina'
PT87005A (pt) Process for preparing n-phenethylaminoalkyl-benzamide anti-arrhythmic agents
DE3468875D1 (en) Substituted isoquinoline derivatives, method for their preparation, and pharmaceutical compositions containing these compounds
HUT45059A (en) Process for producing abeoergoline derivatives
ATE29133T1 (de) Troponon-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung.
DE3781044D1 (de) Prophylaktische und heilende zusammensetzung enthaltende eine 8-chlorbenzothiazepin-verbindung und dessen verwendung.